{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:08:31Z","timestamp":1787580511591,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12308-023-00539-6","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:03:24Z","timestamp":1679504604000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5920-2497","authenticated-orcid":false,"given":"Jia-Rong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chun","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ling","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Mei","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo-Ho","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"8","key":"539_CR1","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/leu.2009.33","volume":"23","author":"C Meyer","year":"2009","unstructured":"Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J et al (2009) New insights to the MLL recombinome of acute leukemias. Leukemia 23(8):1490\u20131499. https:\/\/doi.org\/10.1038\/leu.2009.33","journal-title":"Leukemia"},{"issue":"6","key":"539_CR2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/pbc.23274","volume":"58","author":"TN Sam","year":"2012","unstructured":"Sam TN, Kersey JH, Linabery AM, Johnson KJ, Heerema NA, Hilden JM et al (2012) MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children\u2019s Oncology Group (COG) study. Pediatr Blood Cancer 58(6):836\u2013839. https:\/\/doi.org\/10.1002\/pbc.23274","journal-title":"Pediatr Blood Cancer"},{"key":"539_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.canlet.2019.11.005","volume":"469","author":"MO Forgione","year":"2020","unstructured":"Forgione MO, McClure BJ, Eadie LN, Yeung DT, White DL (2020) KMT2A rearranged acute lymphoblastic leukaemia: unravelling the genomic complexity and heterogeneity of this high-risk disease. Cancer Lett 469:410\u2013418. https:\/\/doi.org\/10.1016\/j.canlet.2019.11.005","journal-title":"Cancer Lett"},{"issue":"3","key":"539_CR4","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.4081\/hr.2012.e15","volume":"4","author":"G Carulli","year":"2012","unstructured":"Carulli G, Marini A, Ferreri MI, Azzara A, Ottaviano V, Lari T et al (2012) B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy. Hematol Rep. 4(3):e15. https:\/\/doi.org\/10.4081\/hr.2012.e15","journal-title":"Hematol Rep."},{"issue":"9","key":"539_CR5","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1038\/bcj.2017.89","volume":"7","author":"CL Haddox","year":"2017","unstructured":"Haddox CL, Mangaonkar AA, Chen D, Shi M, He R, Oliveira JL et al (2017) Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A\/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. Blood Cancer J 7(9):e607. https:\/\/doi.org\/10.1038\/bcj.2017.89","journal-title":"Blood Cancer J"},{"issue":"6","key":"539_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/pbc.25953","volume":"63","author":"A Rayes","year":"2016","unstructured":"Rayes A, McMasters RL, O'Brien MM (2016) Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy. Pediatr Blood Cancer 63(6):1113\u20131115. https:\/\/doi.org\/10.1002\/pbc.25953","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"539_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"issue":"7","key":"539_CR8","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"539_CR9","doi-asserted-by":"publisher","unstructured":"Harman JR, Thorne R, Jamilly M, Tapia M, Crump NT, Rice S et al (2021) A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes. Genome Res. https:\/\/doi.org\/10.1101\/gr.268490.120","DOI":"10.1101\/gr.268490.120"},{"issue":"8","key":"539_CR10","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3109\/10428194.2012.753450","volume":"54","author":"S Grammatico","year":"2013","unstructured":"Grammatico S, Vitale A, La Starza R, Gorello P, Angelosanto N, Negulici AD et al (2013) Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)\/TAF15-ZNF384 rearrangement. Leuk Lymphoma 54(8):1802\u20131805. https:\/\/doi.org\/10.3109\/10428194.2012.753450","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"539_CR11","doi-asserted-by":"publisher","first-page":"e27265","DOI":"10.1002\/pbc.27265","volume":"65","author":"MJ Oberley","year":"2018","unstructured":"Oberley MJ, Gaynon PS, Bhojwani D, Pulsipher MA, Gardner RA, Hiemenz MC et al (2018) Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia. Pediatr Blood Cancer 65(9):e27265. https:\/\/doi.org\/10.1002\/pbc.27265","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"539_CR12","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.5858\/2001-125-1227-CALLAS","volume":"125","author":"CH Dunphy","year":"2001","unstructured":"Dunphy CH, Gardner LJ, Evans HL, Javadi N (2001) CD15(+) acute lymphoblastic leukemia and subsequent monoblastic leukemia: persistence of t(4;11) abnormality and B-cell gene rearrangement. Arch Pathol Lab Med 125(9):1227\u20131230. https:\/\/doi.org\/10.5858\/2001-125-1227-CALLAS","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"539_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood.V61.6.1174.1174","volume":"61","author":"M Nagasaka","year":"1983","unstructured":"Nagasaka M, Maeda S, Maeda H, Chen HL, Kita K, Mabuchi O et al (1983) Four cases of t(4;11) acute leukemia and its myelomonocytic nature in infants. Blood 61(6):1174\u20131181","journal-title":"Blood"},{"issue":"1","key":"539_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/blood.V65.1.21.21","volume":"65","author":"RC Stong","year":"1985","unstructured":"Stong RC, Korsmeyer SJ, Parkin JL, Arthur DC, Kersey JH (1985) Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 65(1):21\u201331","journal-title":"Blood"},{"key":"539_CR15","doi-asserted-by":"publisher","first-page":"621627","DOI":"10.1155\/2011\/621627","volume":"2011","author":"F Marchesi","year":"2011","unstructured":"Marchesi F, Girardi K, Avvisati G (2011) Pathogenetic, clinical, and prognostic features of adult t(4;11)(q21;q23)\/MLL-AF4 positive B-cell acute lymphoblastic leukemia. Adv Hematol 2011:621627. https:\/\/doi.org\/10.1155\/2011\/621627","journal-title":"Adv Hematol"},{"issue":"2","key":"539_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/bjh.15812","volume":"186","author":"OM Lucero","year":"2019","unstructured":"Lucero OM, Parker K, Funk T, Dunlap J, Press R, Gardner RA et al (2019) Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure. Br J Haematol 186(2):333\u2013336. https:\/\/doi.org\/10.1111\/bjh.15812","journal-title":"Br J Haematol"},{"key":"539_CR17","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1038\/ncomms12320","volume":"7","author":"E Jacoby","year":"2016","unstructured":"Jacoby E, Nguyen SM, Fountaine TJ, Welp K, Gryder B, Qin H et al (2016) CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun 7:12320. https:\/\/doi.org\/10.1038\/ncomms12320","journal-title":"Nat Commun"},{"issue":"4","key":"539_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/10935266211001308","volume":"24","author":"J Du","year":"2021","unstructured":"Du J, Chisholm KM, Tsuchiya K, Leger K, Lee BM, Rutledge JC et al (2021) Lineage switch in an infant B-lymphoblastic leukemia with t(1;11)(p32;q23); KMT2A\/EPS15, following blinatumomab therapy. Pediatr Dev Pathol 24(4):378\u2013382. https:\/\/doi.org\/10.1177\/10935266211001308","journal-title":"Pediatr Dev Pathol"},{"key":"539_CR19","doi-asserted-by":"publisher","unstructured":"Semchenkova A, Mikhailova E, Komkov A, Gaskova M, Abasov R, Matveev E et al (2022) Lineage conversion in pediatric B-cell precursor acute leukemia under blinatumomab therapy. Int J Mol Sci 23(7). https:\/\/doi.org\/10.3390\/ijms23074019","DOI":"10.3390\/ijms23074019"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-023-00539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-023-00539-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-023-00539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T01:06:46Z","timestamp":1711069606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-023-00539-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1007\/s12308-023-00539-6","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was not supported by any funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}